Glial implications in transplantation therapy of spinal cord injury

Chinese Journal of Traumatology - English Edition

Volumn 12, Issue 1, 2009, Pages 55-61

  Chen, Shi Wen ^a   Xie, Yu Feng ^b,c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Neuroglia; Spinal cord injuries; Stem cell transplantation

Indexed keywords

APOPTOSIS; ASTROCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSPLANTATION; DISEASE SEVERITY; GLIA CELL; HUMAN; MICROGLIA; NEURAL STEM CELL; NEUROLOGIC DISEASE; NONHUMAN; OLFACTORY ENSHEATHING CELL; OLIGODENDROGLIA; PATHOPHYSIOLOGY; REVIEW; SCHWANN CELL; SPINAL CORD INJURY;

EID: 63449089759     PISSN: 10081275     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1008-1275.2009.01.011     Document Type: Review

References (68)

1. Kwon BK, Tetzlaff W, Grauer JN, et al. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 2004; 4(4): 451-464.
2. Ambrozaitis KV, Kontautas E, Spakauskas B, et al. Pathophysiology of acute spinal cord injury. Medicina (Kaunas) 2006;42(3): 255-261.
3. Springer JE, Azbill RD, Nottingham SA, et al. Calcineurin-mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury. J Neurosci 2000; 20(19): 7246-7251.
4. Wang X, Arcuino G, Takano T, et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 2004; 10(8): 821-827.
5. Nashmi R, Fehlings MG. Mechanisms of axonal dys-function after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels. Brain Res Rev 2001; 38(1-2): 165-191.
6. Schwartz G, Fehlings MG. Secondary injury mechanisms of spinal cord trauma: a novel therapeutic approach for the management of secondary pathophysiology with the sodium channel blocker riluzole. Prog Brain Res 2002; 137(2): 177-190.
7. Gomes-Leal W, Corkill DJ, Freire MA, et al. Astrocytosis, microglia activation, oligodendrocyte degeneration, and pyknosis following acute spinal cord injury. Exp Neurol 2004; 190(2): 456-467.
8. Zhang YW, Denham J, Thies RS. Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors. Stem Cells Dev 2006; 15(6): 943-952.
9. Love R. Stem-cell derived astrocytes promote repair of spinal cord. Lancet Neurol 2006; 5(6): 474-475.
10. Lang B, Liu HL, Liu R, et al. Astrocytes in injured adult rat spinal cord may acquire the potential of neural stem cells. Neuroscience 2004; 128(4): 775-783.
11. Miller RH. Building bridges with astrocytes for spinal cord repair. J Biol 2006; 5(3): 6.
12. Giaume C, Kirchhoff F, Matute C, et al. Glia: the fulcrum of brain diseases. Cell Death Differ 2007; 14(7): 1324-1335.
13. Du Y, Dreyfus CF. Oligodendrocytes as providers of growth factors. J Neurosci Res 2002; 68(6): 647-654.
14. Xie YF, Zhang S, Chiang CY, et al. Involvement of glia in central sensitization in trigeminal subnucleus caudalis (medullary dorsal horn). Brain Behav Immun 2007; 21(5): 634-641.
15. Xie YF. The updated advancements in synaptic plasticity mediated by glial cells. Prog Physiol Sci 2007; 38(2): 111-115.
16. Grossman SD, Rosenberg LJ, Wrathall JR. Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion. Exp Neurol 2001; 168(2): 273-282.
17. Rosenberg LJ, Zai LJ, Wrathall JR. Chronic alterations in the cellular composition of spinal cord white matter following contusion injury. Glia 2005; 49(1): 107-120.
18. Wrathall JR, Li W, Hudson LD. Myelin gene expression after experimental contusive spinal cord injury. J Neurosci 1998; 18(21): 8780-8793.
19. Casha S, Yu WR, Fehlings MG. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 2001; 103(1): 203-218.
20. Xu GY, Hughes MG, Ye Z, et al. Concentrations of glutamate released following spinal cord injury kill oligodendrocytes in the spinal cord. Exp Neurol 2004; 187(2): 329-336.
21. Park E, Liu Y, Fehlings MG. Changes in glial cell white matter AMPA receptor expression after spinal cord injury and relationship to apoptotic cell death. Exp Neurol 2003; 182(1): 35-48.
22. Karadottir R, Cavelier P, Bergersen LH, et al. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005; 438(7071): 1162-1166.
23. Li GL, Farooque M, Holtz A, et al. Apoptosis of oligodendrocytes occurs for long distances away from the primary injury after compression trauma to rat spinal cord. Acta Neuropathol (Berl) 1999; 98(5): 473-480.
24. Tripathi R, McTigue DM. Prominent oligodendrocyte genesis along the border of spinal contusion lesions. Glia 2007; 55 (7): 698-711.
25. Li QM, Tep C, Yune TY, et al. Opposite regulation of oligodendrocyte apoptosis by JNK3 and Pin1 after spinal cord injury. J Neurosci 2007; 27(31): 8395-8404.
26. McGee AW, Strittmatter SM. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration. Trends Neurosci 2003; 26(4): 193-198.
27. Walmsley AR, Mir AK. Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury. Curr Pharm Des 2007; 13(24): 2470-2484.
28. Beattie MS, Hermann GE, Rogers RC, et al. Cell death in models of spinal cord injury. Prog Brain Res 2002; 137(1):37-47.
29. Ridet JL, Malhotra SK, Privat A, et al. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 1997; 20(12): 570-577.
30. Nesic O, Lee J, Ye Z, et al. Acute and chronic changes in aquaporin 4 expression after spinal cord injury. Neuroscience 2006; 143(3): 779-792.
31. Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci 2004; 5(2): 146-156.
32. Faulkner JR, Herrmann JE, Woo MJ, et al. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 2004; 24(9): 2143-2155.
33. Du Y, Chen CP, Tseng CY, et al. Astroglia-mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity. Glia 2007; 55(5): 463-472.
34. Zai LJ, Wrathall JR. Cell proliferation and replacement following contusive spinal cord injury. Glia 2005; 50(3):247-257.
35. McTigue DM, Wei P, Stokes BT. Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. J Neurosci 2001; 21(10):3392-3400.
36. Namiki J, Tator CH. Cell proliferation and nestin expression in the ependyma of the adult rat spinal cord after injury. J Neuropathol Exp Neurol 1999; 58(5):489-498.
37. Yamamoto S, Yamamoto N, Kitamura T, et al. Proliferation of parenchymal neural progenitors in response to injury in the adult rat spinal cord. Exp Neurol 2001; 172(1):115-127.
38. Weiss S, Dunne C, Hewson J, et al. Multipotent CNS stem cells are present in the adult mammalian spinal coral and ventricular neuroaxis. J Neurosci 1996; 16(23):7599-7609.
39. Homer PJ, Power AE, Kempermann G, et al. Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci 2000; 20(6):2218-2228.
40. Horky LL, Galimi F, Gage FH, et al. Fate of endogenous stem/progenitor cells following spinal cord injury. J Comp Neurol 2006; 498(4):525-538.
41. Lavdas AA, Papastefanaki F, Thomaidou D, et al. Schwann cell transplantation for CNS repair. Curr Med Chem 2008; 15(2): 151-160.
42. Zhang X, Zeng Y, Zhang W, et al. Co-transplantation of neural stem cells and NT-3-overexpressing Schwann cells in transected spinal cord. J Neurotrauma 2007; 24(12): 1863-1877.
43. Zeng YS, Ding Y, Wu LZ, et al. Co-transplantation of schwann cells promotes the survival and differentiation of neural stem cells transplanted into the injured spinal cord. Dev Neurosci 2005; 27(1):20-26.
44. Li J, Sun CR, Zhang H, et al. Induction of functional recovery by co-transplantation of neural stem cells and Schwann cells in a rat spinal cord contusion injury model. Biomed Environ Sci 2007; 20(3):242-249.
45. Andrews MR, Stelzner DJ. Evaluation of olfactory ensheathing and Schwann cells after implantation into a dorsal injury of adult rat spinal cord. J Neurotrauma 2007; 24(11):1773-1792.
46. Shibuya S, Miyamoto O, Itano T, et al. Temporal progressive antigen expression in radial glia after contusive spinal cord injury in adult rats. Glia 2003; 42(2):172-183.
47. Wu D, Miyamoto O, Shibuya S, et al. Co-expression of radial glial marker in macrophages/microglia in rat spinal cord contusion injury model. Brain Res 2005; 1051 (1-2): 183-188.
48. Hasegawa K, Chang YW, Li H, et al. Embryonic radial glia bridge spinal cord lesions and promote functional recovery following spinal cord injury. Exp Neurol 2005; 193(2):394-410.
49. Keirstead HS, Nistor G, Bernal G, et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005; 25(19):4694-4705.
50. Cloutier F, Siegenthaler MM, Nistor G, et al. Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm. Regen Med 2006; 1(4):469-479.
51. Davies JE, Huang C, Proschel C, et al. Astrocytes derived from glial-restricted precursors promote spinal cord repair. J Biol 2006; 5(3):7.
52. Lee KH, Yoon DH, Park YG, et al. Effects of glial transplantation on functional recovery following acute spinal cord injury. J Neurotrauma 2005; 22(5):575-589.
53. Ziv Y, Avidan H, Pluchino S, et al. Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proc Natl Acad Sci USA 2006; 103(35):13174-13179.
54. Choi D, Law S, Raisman G, et al. Olfactory ensheathing cells in the nasal mucosa of the rat and human. Br J Neurosurg 2008; 22(2):301-302.
55. Iwatsuki K, Yoshimine T, Kishima H, et al. Transplantation of olfactory mucosa following spinal cord injury promotes recovery in rats. Neuroreport 2008; 19(13):1249-1252.
56. Radtke C, Sasaki M, Lankford KL, et al. Potential of olfactory ensheathing cells for cell-based therapy in spinal cord injury. J Rehabil Res Dev 2008; 45(1): 141-152.
57. Zhang J, Wang B, Xiao Z, et al. Olfactory ensheathing cells promote proliferation and inhibit neuronal differentiation of neural progenitor cells through activation of Notch signaling. Neuroscience 2008; 153(2):406-413.
58. Barnett SC, Riddell JS. Olfactory ensheathing cell transplantation as a strategy for spinal cord repair - what can it achieve? Nat Clin Pract Neurol 2007; 3(3): 152-161.
59. Richter MW, Roskams AJ. Olfactory ensheathing cell transplantation following spinal cord injury: hype or hope? Exp Neurol 2008; 209(2):353-367.
60. Yuan TF. Olfactory ensheathing cells transplantation for spinal cord injury treatment: still a long way to go. Med Hypotheses 2008; 71(1):153-154.
61. Parr AM, Kulbatski I, Tator CH. Transplantation of adult rat spinal cord stem/progenitor cells for spinal cord injury. J Neurotrauma 2007; 24(5):835-845.
62. Fujiwara Y, Tanaka N, Ishida O, et al. Intravenously injected neural progenitor cells of transgenic rats can migrate to the injured spinal cord and differentiate into neurons, astrocytes and oligodendrocytes. Neurosci Lett 2004; 366(3):287-291.
63. Takano T, Tian GF, Peng W, et al. Astrocyte-mediated control of cerebral blood flow. Nat Neurosci 2006; 9(2):260-267.
64. Weible MW 2nd, Chan-Ling T. Phenotypic characterization of neural stem cells from human fetal spinal cord: synergistic effect of LIF and BMP4 to generate astrocytes. Glia 2007; 55(11): 1156-1168.
65. Ishii K, Nakamura M, Dai H, et al. Neutralization of ciliary neurotrophic factor reduces astrocyte production from transplanted neural stem cells and promotes regeneration of corticospinal tract fibers in spinal cord injury. J Neurosci Res 2006; 84 (8): 1669-1681.
66. Lytle JM, Chittajallu R, Wrathall JR, et al. NG2 cell response in the CNP-EGFP mouse after contusive spinal cord injury. Glia 2008.
67. Bunge MB. Novel combination strategies to repair the injured mammalian spinal cord. J Spinal Cord Med 2008; 31 (3): 262-269.
68. Deng Y, Liu Y, Zhu W, et al. The co-transplantation of human bone marrow stromal cells and embryo olfactory ensheathing cells as a new approach to treat spinal cord injury in a rat model. Cytotherapy 2008; 10(1): 1-14.